Carcinoma ass. Antigen

The cure opportunity and treatment options of head and neck squamous cell carcinoma depend to a large extent on the extent of the disease, which is clinically evaluated through examination, palpation and radiology. Since part of the reason for treatment failure is that no metastasis was detected clinically during treatment, more specific tumor detection methods are needed. In the case of cancer, attempts to develop antibodies that recognize tumor-associated antigens have resulted in the isolation of a large number of antibodies that react with high-molecular-weight glycoproteins.